EOFLOW Co.,Ltd. Stock price

Equities

A294090

KR7294090006

Medical Equipment, Supplies & Distribution

End-of-day quote Korea Stock Exchange 06:00:00 2023-12-10 pm EST Intraday chart for EOFLOW Co.,Ltd. 5-day change 1st Jan Change
4,860 KRW -5.45% -48.90% -67.60%
Sales 2022 6.71B 5.08M Sales 2023 * - Capitalization 455B 345M
Net income 2022 -30.71B -23.28M Net income 2023 * - EV / Sales 2022
62,1x
Net cash position 2022 38.12B 28.9M Net cash position 2023 * - 0 EV / Sales 2023 * -
P/E ratio 2022
-14,6x
P/E ratio 2023 *
Employees -
Yield 2022
-
Yield 2023 *
-
Free-Float 80.31%
More Fundamentals * Assessed data
Dynamic Chart
Medtronic Korea Holdings Co., Ltd. cancelled the acquisition of 18.54% stake in EOFLOW Co.,Ltd. from Jaejin Kim. CI
US-based Medtronic Acquires EOFlow MT
Eoflow to Raise 314.9 Billion Won via Shares Issuance MT
Medtronic Korea Holdings Co., Ltd. agreed to acquire a 18.54% stake in EOFLOW Co.,Ltd. from Jaejin Kim for approximately KRW 170 billion. CI
EOFLOW Co.,Ltd. announced that it expects to receive KRW 314.903773785 billion in funding from Medtronic Korea Holdings Co., Ltd. CI
Pharmeo Inc. announced that it has received KRW 12.9999435 billion in funding from EOFLOW Co.,Ltd. CI
Pharmeo Inc. announced that it expects to receive KRW 12.9999435 billion in funding from EOFLOW Co.,Ltd. CI
EOFLOW Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
EOFLOW Co.,Ltd. announced that it has received KRW 32 billion in funding from Korea Investment & Securities Co., Ltd., Investment Arm, Mirae Asset Securities Co., Ltd, investment arm, Kiwoom Securities Co., Ltd., Investment Arm, SUSUNG ASSET MANAGEMENT Co., Ltd. CI
EOFLOW Co.,Ltd. announced that it expects to receive KRW 32 billion in funding from Korea Investment & Securities Co., Ltd., Investment Arm, Mirae Asset Securities Co., Ltd, investment arm, Kiwoom Securities Co., Ltd., Investment Arm, SUSUNG ASSET MANAGEMENT Co., Ltd. CI
Pharmeo Inc. announced that it has received KRW 9.9078 billion in funding from EOFLOW Co.,Ltd. CI
Pharmeo Inc. announced that it expects to receive KRW 9.9078 billion in funding from EOFLOW Co.,Ltd. CI
Diabeloop and EOFLOW Co.,Ltd. Partners to Offer Wearable Aid with Smartphone App CI
EOFlow Co., Ltd. Submits Application to the U.S. FDA for its Wearable Insulin Pump 'EOPatch' CI
EOFLOW Co.,Ltd. and Zihipp Limited Announce Joint Venture for Development of Innovative Solutions for Treatment of Obesity & Nash CI
More news
1 day-5.45%
1 week-48.90%
Current month-41.38%
1 month-77.60%
3 months-80.83%
6 months-82.83%
Current year-67.60%
More quotes
1 week
4 740.00
Extreme 4740
11 450.00
1 month
4 740.00
Extreme 4740
17 420.00
Current year
4 740.00
Extreme 4740
29 150.00
1 year
4 740.00
Extreme 4740
29 150.00
3 years
4 740.00
Extreme 4740
42 150.00
5 years
4 740.00
Extreme 4740
42 150.00
10 years
4 740.00
Extreme 4740
42 150.00
More quotes
Managers TitleAgeSince
Founder 62 -
President 60 2017
Chief Tech/Sci/R&D Officer 62 2018
Members of the board TitleAgeSince
Founder 62 -
Director/Board Member 65 -
Director/Board Member 60 -
More insiders
Date Price Change Volume
23-12-10 4,860 -5.45% 8 017 049
23-12-08 5,140 -28.71% 20,314,870
23-12-07 7,210 -29.93% 216,377
23-12-06 10,290 -6.88% 336,006
23-12-05 11,050 +16.32% 1,162,701

End-of-day quote Korea Stock Exchange, December 10, 2023

More quotes
EOFlow Co Ltd is a Korea-based company mainly engaged in the manufacture and sale of medical devices. The Company's main products include wearable insulin pumps, insulin infusion regulators for blood sugar control in diabetic patients.
More about the company

Annual profits - Rate of surprise

1st Jan change Capi.
-67.60% 119 M $
+0.47% 8 647 M $
-18.29% 6 427 M $
+3.74% 6 029 M $
-31.26% 5 515 M $
+29.21% 5 276 M $
+6.50% 4 610 M $
-3.51% 3 631 M $
+28.86% 3 551 M $
-27.45% 2 423 M $
Medical Equipment
  1. Stock
  2. Equities
  3. Stock EOFLOW Co.,Ltd. - Korea Stock Exchange
As early as today, start finding the best investment opportunities!
Optimize my profits
fermer